GB2054372A - Examining blood vessels - Google Patents

Examining blood vessels Download PDF

Info

Publication number
GB2054372A
GB2054372A GB8018817A GB8018817A GB2054372A GB 2054372 A GB2054372 A GB 2054372A GB 8018817 A GB8018817 A GB 8018817A GB 8018817 A GB8018817 A GB 8018817A GB 2054372 A GB2054372 A GB 2054372A
Authority
GB
United Kingdom
Prior art keywords
particles
coronary
blood
sources
particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8018817A
Other versions
GB2054372B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB8018817A priority Critical patent/GB2054372B/en
Publication of GB2054372A publication Critical patent/GB2054372A/en
Application granted granted Critical
Publication of GB2054372B publication Critical patent/GB2054372B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/42Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/4258Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Abstract

Particles of dimensions not greater than 8 microns capable of providing detectable signals, are introduced into the blood for examination of a blood vessel. The particles may be sources of radiation, e.g. Ga68.

Description

SPECIFICATION Improvements in or relating to the examination of blood vessels of interest This invention is concerned with improvements in or relating to the examination of blood vessels of interest.
Coronary heart disease accounts for almost twothirds of the deaths in the western world of adult males aged 30 to 64 years. Of all individuals sustaining their first myocardial infarction, more than half have had neither preceding signs nor symptoms of coronary heart disease. It is therefore desirable to make early determinations of the existence, location and severity of coronary stenotic lesions in a manner that is convenient for the examination of a large number of individuals.
At present, coronary arteriography yields more useful information about the state of the coronary arteries than any other technique. However, the mortality rate and the incidence of major complications involved with this procedure are unacceptably high and the procedure is painful, expensive and timeconsuming. For these reasons, coronary angiography is not performed upon symptomatic individuals and is not suitable for screening large populations.
In the specification of my copending U.K. patent application no. 7837906, there is disclosed apparatus for interacting with a number of particles which can be introduced into the blood of a subject and which can provide signals from within a vessel of interest that can be detected outside the body, the apparatus comprising detector means positionable near the body of the subject for detecting the signals from the number of particles at successive locations of each of the number of particles at successive times during the travel of each particle through a vessel of interest; circuit means coupled to said detector means for providing output manifestations from successive positions of each of the number of particles at successive times during the travel thereof through the vessel of interest; and output means responsive to the output manifestations from said circuit means for providing an indication of the relative internal cross-sectional areas of the vessel of interest at successive positions along the course of the vessel of interest.
In the aforesaid specification there is also disclosed apparatus for interacting with a number of particles which can be introduced into the blood of a subject and which can provide signals from within a vessel of interest that can be detected outside the body, the apparatus comprising detector means positionable near the body of the subject for receiving the signals emanating from the body of the subject to produce electrical signals in response thereto which are indicative of the successive locations of a particle from which the received signals emanated from the body; circuit means responsive to said electrical signals for providing output manifestations indicative of the three-dimensional coordinates of successive locations of each of said particles within said vessel of interest as a function of time; and output means responsive to the output manifestations from said circuit means for providing an indication of the course of the vessel.
It is to be understood that the expression "apparatus of the type hereinbefore defined" where used hereinafter is intended to mean apparatus as set forth in either the last preceding paragraph or the last preceding paragraph but one.
The present invention is more especially concerned with the particles which interact with apparatus of the type hereinbefore defined.
Because of the high peripheral resistance of the myocardial vascular bed and the considerable range of autoregulatory resistance changes available to the coronary circulation, coronary stenoses of 80%-90% are required to diminish the volume of coronary blood flow. This propensity of volumetric coronary blood flow to remain normal even in the presence of severe stenoses is responsible for the late occurrence or absence of anginal symptoms and diagnostic electrocardiogram patterns, even in the presence of coronary stenoses, and explains why measurement of volumetric blood flow furnishes poor sensitivity in detecting coronary disease.
However, this propensity of volumetric blood flow to remain normal even in the presence of severe stenosis furnishes a distinctive characteristic that blood flowing through a stenotic arterial segment must have high velocity. In fact, to maintain the constant volumetric flow rate, the average fluid velocity within a stenotic segment of artery must change in strict inverse proportionality to the change in crosssectional areas from normal to stenotic blood vessel.
As coronary stenosis becomes more severe, the increments in blood flow velocity become progressively greater.
The present invention provides particles for interaction with apparatus of the type hereinbefore defined and which can be introduced into the blood of a subject, the particles each having dimensions not greater than approximately 8 microns for passing through capillary beds of the body of the subject.
The particles are preferably sources of radiation.
It is preferred that the sources of radiation produce gamma rays. Preferably the sources of radiation each produce gamma ray pairs that propagate substantially in opposite directions from the region of a respective particle.
It is further preferred that the sources of radiation each emit positrons at an energy level of less than approximately 1 MeV.
Preferably the particles comprise gallium63.
In use, particles according to the invention are injected intravenously and become randomly distributed in the circulating blood volume. The particles are tracked in three dimensions whenever they appear in the region of the heart by means of high The date of filing shown above is that provisionally accorded to the application in accordance with the provisions of Section 15(4) of the Patents Act 1977 and is subject to ratification or amendment at a later stage of the application proceedings.
resolution high-speed gamma detectors that sur round the chest. These recordings of particle posi tion as a function oftime are analyzed and whenever a particle follows a flow path indicating that it is pas sing through a coronary artery, the velocity of blood as it flows through the artery is measured by timing the transit of the particle. From the accumulated data of multiple particle transits through the coronary circulation, a three-dimensional representation of the lumen of the coronary arterial system is constructed.
There now follows a description which is to be read with reference to the accompanying drawings of particles according to the invention and of an example of apparatus of the type hereinbefore defined; it is to be clearly understood that the particles have been selected for description to illustrate the present invention by way of example and not by way of limitation.
In the accompanying drawings:- Figure lisa pictorial view of a human heart showing the principal coronary arteries: Figure 2 is a schematic diagram of an apparatus of the type hereinbefore defined showing radiation detectors disposed about the region of the heart of a subject; Figure 3 is a schematic diagram of a conventional multi-wire proportional chamber which may be used as the detectors in the apparatus of Figure 2; Figure 4 is a process diagram showing operation of the data processor of Figure 2; Figure 5 is a pictorial representation of data accumulated during a single time bin of operation; and Figure 6 is a pictorial representation of displayed data patterns representative of various particle tra jectories in and about the heart a subject.
There are three main coronary arteries which branch somewhat irregularly to form an average of ten secondary vessels, as shown in Figure 1.
Arteriosclerotic lesions are limited to the epicardial segments of the coronary vessels and rarely extend beyond the most proximal portions of the secondary vessels. The highest concentration of arteriosclerotic lesions is within the first 2 to 3 cm. of the left anterior descendens artery 3, butthe lesions are otherwise rather randomly distributed in the proximal primaryand secondary arteries. Seventy percentofall arteriosclerotic coronary lesions are found within the proximal 4 cm. of the main coronary arteries.
The average velocity of blood flow through the epicardial coronary blood vessels is of the order of 30 cm/sec. A 50% stenosis is generally considered to be significant. To be useful, the system should be capable of discriminating between normal vessels and 50% stenotic lesions and should be capable of assessing additional significant decrements in the cross sections of these vessels.
Typical blood flow velocities through stenoses of varying degrees are as follows: Degree ofStenosis Average Velocity 0% 30 cm/sec 50% 60 cm/sec 60% 75 cm/sec 70% 100cm[sec 80% 150cm/sec 90% 300 cm/sec Since nominal resting coronary flow velocity is about 30 cm/sec,ideally the system should be able tao differentiate a flow velocity of 60-75 cm/sec from 30 cm/sec in order to detect significant lesions and discriminate between velocities of 75, 100, 150, and 300 cm/sec in order to follow additional 10% increments in stenoses.
Positron-emitting particles are known which can travel some millimeters in blood or tissue before coming to rest. They will then be captured by an electron in the local tissue and both particles will be annihilated producing two gamma rays, each of 511 KeV moving in almost exactly opposite directions.
The gamma rays can be detected at some distance with good spatial resolution, and a straight line joining the points at which the gamma rays were detected passes through their mutual point of origin and within a few millimeters of the positron-emitting source. By detecting a number of gamma pairs from a single stationary source, lines drawn between detected pairs will intersect at one point in space and define the position of the position-emitting source.
Typically, conventional detectors have spatial resolutions of the order of a centimeter. Since the organ being examined is normaily stationary, additional resolution is obtained by observing a statistically large number of counts.
A number of discrete moving positron-emitting sources present in the circulating blood is tracked.
The system not only locates the position of the sources in three dimensions, but also locates them again and again at very short time intervals. The requirement as to how often a particle source must be located is determined from the following considerations.
As noted above, cm/sec is about the nominal velocity of blood flow through a coronary artery for a subject at rest. Blood flow through a diseased arterial segment which is 80% stenotic will have a velocity five times this nominal value (150 cm/sec.). Blood flowing through a segment of a blood vessel with a severe 90% stenosis will have a velocity of the order of 300 cm/sec. In order to measure a 90% stenosis that is 1 cm long, a particle moving through the stenosis should be deteeted at least a few times. At 300 cm/sec, only three milli-seconds are required tot pass through a 1 cm length of vessel. If three determinations of position are desirable during this interval, a half-dozen coineident pairs of gamma rays must be detected during the three milliseconds and a minimum detection rate of 2,000 gamma pairs per second is indicated.
The detector subtends about two-thirds of the total solid angle surrounding the heart. Each gamma ray has a 50% probability of leaving the body unde flected. There is thus a (.5)2 = .25 .25 probabality that both members of a gamma pairwill emerge from the body undeflected.
If the detecting element has a 20% efficiency for detecting a gamma ray incident upon it, then there is (.20) 2 = .04 probability of detecting both members of a coincident pair. Multiplying these members together furnishes the over-all probability that a positron annihilation will produce a detected pair of P = .67 x .25 x .04 = .006, Thus, it takes 150 annihilations on the average to produce one detected pair. For 2,000 detected gamma pairs per second, each source must emit 2,000 x 150 =3x 105 positrons per second. 3.7 x 105 positrons per second correspond to a 10 microcurie source, so individual source intensities on the order of 10 microcuries are indicated.
Sources of this or many times greater intensity are routinely available, but the particles used in this application must be sufficiently small to pass through capillary beds, if they are to be injected by simple veni-punctures and find their way to the coronary arteries. Fortunately, there exists a considerable number of positron emitters (such as Gal ilium66) which have half-lives of sufficiently short duration so that a small number of atoms produce a high decay rate. For example, Gallium66 has a halflife of only 68 minutes and can be readily, conveniently, and inexpensively "milked" from Ger minium66, an isotope with about 270 days half-life. A pure Gallium source of one cubic micron volume has an intensity of 230 microcuries.While pure Gallium66 is unsuitable because it is a liquid atbodytempera- ture, the large carrier-to-active material ratios for particles having a short dimension less than 6-8 microns suggest that Gallium68 either compounded or absorbed in carrier particles would provide a suitable source.
As noted above, there are three main coronary arteries which branch into an average of ten secondary branches. If, for statistical purposes, it is desired that three velocity measurements be made through each of the ten secondary branches, then a total 3 x 10 = 30 particle transits through the coronary system would be required. This would furnish approximately 10 transits through each of the proximal principle coronary arteries where most of the atheromatous lesions are located.
Since coronary blood flow approximates only 5% of the cardiac dutput at rest, a given particle has only a .05 probability of entering the coronary circulation after a single pass through the heart. Thus, 20 circulations through the heart times 30 particle transits through the coronary system, or a total of 600 particle transits through the circulation would furnish the redundancy of coronary blood flow velocity measurements outlined above.
Since the mean circulation time is one minute or less, a single particle tracked in the circulation for 600 minutes would be suitable for the outlined redundancy, if its half-life were sufficiently long and if it continued to circulate for the ten-hour period. Of course, ten hours is an inconveniently long duration for a diagnostic measurement. Forty particles cir culatingforfifteen minutes would be much more convenient and would furnish a comparable 600 particle transit through the circulatory system.
The number of particles required to attain 600 particle transits through the circulation is influenced by the possibility that the positron-emitting particles may be removed from the circulation by the Kupfer cells of the liver. The propensity of the liver to extract particles is a function of their size and surface characteristics, of the state of the reticu loendothelial system as influenced by pre-treatment and otherwise, and a function of other variables.
Liver blood flow is on the order of 20%-25% of cardiac output at rest. If particles are extracted by the liver with 100% efficiency, a total of 160 particles would have to be administered and the examination conducted for a fifteen-minute period in order to furnish the desired 600 circulatory transits under these circumstances. A reasonable programe of particle administration might begin with an initial intravenous injection of 50 particles, with 12 particles injected at the end of each of nine subsequent 1-minute periods. Alternatively, if particles are extracted from the liver with less than 100% efficiency, the number of particles required for fifteenminute examination would fall between 160 and 40.
The number of particles used for an examination is important in two regards: the radiation exposure of the patient and the complexity of the data processing required. If liver extraction is 100% efficient, the total administered dose to 160 particles x 10 microcuries per particle = 1.6 millicuries, which compares favourably with the 2 millicurie Gallium66 dose currently administered for bone scanning. Radiation to the liver for this worst case is 3 rads, which compares favorably with the liver dose of 6 rads which results from conventional liver scans using Gold166.
However, if the circulating particles are not picked up by the liver during the fifteen-minute examination time, only 40 particles constituting 0.4 millicurie need be administered. Since Gallium66 has a radioactive half-life of only 68 minutes, if the circulating particles are not extracted by the liver over a period of a few hours, radiation of the liver is essentially zero and radiation to the rest of the body is so widely dispersed as to be negligible.
The complexity of data processing is significantly influenced by the number of particles that must be simultaneously detected in the field of view which encompasses the heart. The coincidence circuit 9 and gates 11, 13, shown in Figure 2, connected to the gamma detectors 7, 8 of the type shown in Figure 3, constitute a preprocessing ci rcuit that accepts only those gamma rays which occur as synchronous pairs and which emerge from the general region of the heart. The field of view of detectors 7 and 8 thus situated contains only 5%-7% of the total blood vol ume. Even if the efficiency of hepatic extraction is 100%, the total number of particles in the entire circulating blood volume at any one time need be no more than 50 to obtain the highly redundant number of measurements described above. Under these extreme circumstances, no more than 34 particles need be in the field of view at any one time, a very acceptable number for uncomplicated data proces sing.
The detectors 7 and 8 consist of two or more pairs of detecting modules, for example, of the type shown in Figure 3, which surround the thorax, as shown in Figure 2, and locate the arriving gamma rays to an accuracy of about a millimeter. This infor mation, which exists in the form of electrical pulses, is stored, say on tape or disc, depending on the rate of events, for subsequent computer processing. As noted, only gamma rays that arrive synchronously on opposing detectors 7 and 8 in Figure 2 and only synchronous pairs that could have originated in the region of the heart are accepted for recording. Thus, gamma rays 7a that arrive synchronously from a region beyond the heart may be conveniently rejected as irrelevant data.
Subsequent computer processing of the stored data constructs straight lines in space corresponding to the inferred flight paths of the recorded gamma rays as represented in the pictorial presentation of Figure 5. Three times out of four, at least one of the gamma rays will have been Compton scattered, producing a line 50 which does not pass through the point at which the gamma rays actually originated.
These lines 50 are rejected in the data analysis because they do not consistently intersect other lines in the region of the same slowly-moving point in space. Intersections of the "true" lines will cluster together near one point 54 in space, corresponding to location of a source at a given time, which moves a velocity of a few tens or hundreds of cm/sec. The intersections 53 of "spurious" lines are scattered randomly about and do not converge near any point.
It is desirable to minimize this background clutter of spurious lines against which the sources must be "seen", since the "true" lines do not pass through a perfect point of intersection, but through a region of ambiguity of a few millimeters in size, smeared by the variable distances and directions in which the positrons move from the source before annihilating and by the motion ofthesurfaceofthe heart, where the coronary arteries of interest are located. The system can be operated through synchronized gates in order to observe sources only during the diastolic phase of the cardiac cycle when heart motion is least and the velocity of blood in the coronary arteries is greatest and most constant.Cardiac diastole characteristically occupies 400-600 milliseconds, which is considerably longer than the transit time (30-300 mil- liseconds) required for a particle to flow through a 10 cm length of coronary artery. As a result, data may be accumulated during a single diastolic period to provide a plurality of ray-intersection "clusters", as represented pictorially in Figure 5.
Further computer processing of the intersections of the "true" straight lines reconstructs the positions of the function of time as they passed in the circulating blood through the field of view of the pairs of detector modules 7, 8 of Figure 2. These intersections are accumulated in a number of time bins and are reconstructed to represent the flow paths of the particles. In practice, an operator may conveniently interface with the computer during this phase of data analysis to discriminate between the flow paths which represent transit through a coronary vessel and the flow paths which represent entrance to and exit from the chambers of the heart.This type of operator discrimination is simplified by the fact that these two kinds of flow paths are quite difference, both spatially and with respect to relative flow velocities during the various phases of the cardiac cycle, and by the fact that an average of only three to four particles are typically in view at any one time.
In operation, then, an event is accepted by the hard-wired electronics if a signal is received at two - detector chambers within about 50 nanoseconds and if the spatial locations of the two chambers indicate the event originated in a small volume encompassing the heart. These events may be stored, for example, in a disc memory device.
The information thus stored may typically consist of 20 bits for the x, y coordinates for each side of the detector, and 4 bits for gap identification within the module, if a multiple layer multi-wire proportional chamber is used as the detector. Thus, each event (a synchronous pair of gamma rays) may require four 12-bit words to identify it. In addition, ECG information and a 10 millisecond time marker may be stored on the disc to allow for correlation between the event and the cardiac cycle. Analysis may then be performed by the following steps: Starting with the onset of cardiac diastole, the data can be divided into 10 millisecond time bins. Each bin may be analyzed on a 10 by 10 by 10 cm" matrix where the unit volume is 1 cubic cm.Each intersection of two or more lines (corresponding to the synchronous pair of gamma rays) within a unit volume is stored as an event and only those unit volumes with more than 5 (or 10) events stored in them will be selected. On the average, not more than two to five unit volumes will satisfy this criteria for each time bin. Storage may be provided for ten of them. The counts in the unit volume selected and its position may thus be stored separately and the process will be repeated for the next 10 millisecond period. Once all intervals within a diastolic period are analyzed, the inter-sections representative of the positions of the particles can be displayed sequentially, as shown pictorially in Figure 6, for all time bins during a diastolic period. Particles that were resident in the cardiac chambers during diastole exhibit characteristic lines 57 having short random segments.Particles that flowed through a coronary vessel during diastole exhibit a long line 58 of characteristic contour corresponding to the course of a coronary artery. An operator may view these data patterns which represent transits of particles in and about the heart and perform simple data selection based upon the geometry of the flow transit paths 57, 58. Data corresponding to particles which passed through a coronary artery are selected and data correspondinq to particles which entered into and resided in a cardiac chamber (or took some other extra-coronary path such as through a lung) are rejected.
The data thus selected for each path of interest during a diastolic period can be redisplayed on an effectively expanded time scale in order to determine the sequential location of each particle with greatertime resolution. In stenotic regions of faster blood flow, a lower number of events per unit volume will be encountered and this information about sequential locations of a particle with respect to time is used to determine the relative velocities of a parti cle over the total course of the flow path along the coronary artery.
This process can be repeated for all diastolic periods ofthe examination and, from the information thus accumulated, the existence, location, severity and extent of stenotic and dilated regions of the coronary arteries can be determined.
One important constraint governing the suitability of a positron source concerns the energy of the positrons emitted. It is desirable to limitthe range that the positron travels in tissue before annihilation and conversion to gamma pairs in order to minimize the sphere of confusion in inferring the radionuclide position from intersection of the lines-of-flight of gamma pairs. Since the range of 1 MeV positron is about 0.5 gm/cm2 or 5mm in tissue, it is desirable to have the mean positron energy below 1 MeV. The circulating particles should be no larger in their smallest diameterthan 6-8 microns so that they will freely pass through capillary beds and each particle should produce at least 3 x 1 05 positrons per second.The specific activity (number of radioactive decays/second/gram) of a radionuclide required to furnish this positron rate in a particle of the small size indicated will depend upon the physiochemical properties of the radionuclide and the manner in which it forms particulates with carrier materials.
The specific activity of a radionuclide is inversely proportional to its half-life. Acceptable half-lives musttake into accountthe method of production of the radionuclide and the time required to chemically or physically convert the radionuclide into suitable particle form.
Gallium66 is an attractive source candidate, because of its following radioactive properties: half-life 68 minutes decay product stable68Zn modes of decay 88% of which 86% goes to ground state of 68on mean positron energy 1 MeV production from decay of Germanium68, which has a half-life of 275 days Gallium66 is a short-lived daughter continually produced by a long-lived parent. Germanium66 "cows" are commercially available at low cost (less than $1,000 for the specific activity required for the worst case discussed above). The Gallium66 produced by these generators is conveniently removed from the Germanium cow be eluting with an aqueous EDTA solution. Ga66 can be liberated from the GaEDTA complex by mixing with a strongly acetic iron solution or boiling away the EDTA.
Gallium is a chemically highly reactive element which readily forms many inorganic, insoluble compounds with iron, tin, sulfates, chromates, phosphates, etc. One easily produced crystalline complex is (Ga) (Cr) (PO4)2, formed by adding a phosphate buffered chromic salt to the eluted Ga66-EDTA compled and boiling away the EDTA and water. The resulting crystals may be conventionally pulverized and screened to the requisite size in a diluent suitable for intravascular administration. Of course, other radiation-emitting sources may be used in accordance with the present invention. For example, particulate X-ray sources may be introduced into the blood and the detection may be performed by recurring exposures for brief intervals of photographic film positioned about the thorax of a patient.
The detector system consists of one or more pairs of modules 7,8,7', 8', preferably arranged surrounding the subject's chest as shown in Figure 2. Each module 7,7', 8,8', may be a sandwich of five multiwire proportional chambers coupled to 1 mm lead converters according to conventional design. Such modules have an active area of 50 cm x 50 cm and a total thickness of 5 cm. The .511 MeV annihilation photons are converted to electrons in the lead and the annihilation vectors are determined from two opposing multi-wire proportional chambers (Figure 2). Detectors of this type, where multiplication without sparking is used to determine the position of events, are described in the literature (see, for example, Charpak, et al., Nucl. Inst. Methods 62:262, 1968; 65:217, 1968; 88:149,1970).Detectors of this type may consist of three-wi re grids with the central grid held at a positive d.c. voltage with respect to the outer two grids. For the purpose of gamma ray imaging, one of the outer grids is replaced by a lead con verter which is placed very close to the high voltage grid (=1 mm). The two grids have wires at right angles to each other and can be placed further apart (5-10mm). The conversion electrons in passing through the gas in the chamber produce electron-ion pairs. These electrons are accelerated towards a positive high voltage wire, undergoing rapid multiplication in the high field region surrounding the wire.
This results in a voltage pulse on the wire. A similar pulse is induced on the wires of the ground plane.
Determining the wires on which these pulses occur gives the spatial location of the event. This may be done by capacitively coupling the wire grids to delay lines, as shown in Figure 3. Measuring the time difference between the generation of the pulse and its arrival at the end of the delay line indicates the position of the origin of the pulse on the delay line and thus the spatial location of the event. The pres enttechnique allows spatial location accuracy of 1 mum, data rates of over 106/second and resolving times of the order of 30-60 nano-seconds. Of course, the wire grids may all be coupled to a central processing unit or computer for direct determination and location of simultaneously occurring pairs of annihilation photons.
Even for pure positron-emitting sources, the majority of detected events consists of a single gamma ray, the other escaping the system because of its limited acceptance and detection efficiency.
Also, some of the annihilation photons may convert in tissues surrounding the source, thus further reducing potential coincidence counts in both detectors.
Considering only the hardware-related part of this problem and including a factor of .25 for Compton scatter of the annihilation photons, for identical detectors 7 and 8 mounted symmetrically on four sides of a cube, as shown in Figure 2, we may define: G as the geometric acceptance of the system for the particular source position e as the efficiency for the detection of a single 511 KeV photon N as the number of annihilations per second occurring at the source 7 as the resolving time of the chamber For the case of a pure positron emitter, we set: G = .66 e = .20 T = 50 x 10-9 sec N = 10 microcurie Ci = 3.7 x 105 sec The rate of accidental coincidences A due to the detection oftwo uncorrelated events is: : A = G 2e 2N 27 = 125/sec which is distributed almost uniformly over the field, causing a low background data density. The number of real events R is: R = .25we2 =2.5 x 103/sec concentrated over a small volume. The singles average data rate at each chamber is: S = -Gx -e, N = 4.8 x 103/sec which is well within the capabilities of such a detector.

Claims (7)

1. Particles for interaction with apparatus of the type hereinbefore defined and which can be introduced into the blood of a subject, the particles each having dimensions not greater than approximately 8 microns for passing through capillary beds of the body of the subject.
2. Particles according to claim 1 and which are sources of radiation.
3. Particles according to claim 2 wherein the sources of radiation produce gamma rays.
4. Particles according to either one of claims 2 and 3 wherein the sources of radiation each produce gamma ray pairs that propagate substantially in opposite directions from the region of a respective particle.
5. Particles according to any one of the preceding claims wherein the sources of radiation each emit positrons at an energy level of less than approximately 1 MeV.
6. Particles according to any one the of the preceding claims and comprising Gallium66.
7. Particles according to claim 1 and substantially as hereinbefore described.
GB8018817A 1978-09-23 1978-09-23 Examining blood vessels Expired GB2054372B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8018817A GB2054372B (en) 1978-09-23 1978-09-23 Examining blood vessels

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8018817A GB2054372B (en) 1978-09-23 1978-09-23 Examining blood vessels

Publications (2)

Publication Number Publication Date
GB2054372A true GB2054372A (en) 1981-02-18
GB2054372B GB2054372B (en) 1983-03-02

Family

ID=10513907

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8018817A Expired GB2054372B (en) 1978-09-23 1978-09-23 Examining blood vessels

Country Status (1)

Country Link
GB (1) GB2054372B (en)

Also Published As

Publication number Publication date
GB2054372B (en) 1983-03-02

Similar Documents

Publication Publication Date Title
GB2031142A (en) Apparatus and method for examining a blood vessel of interest using radiation detected outside the body
US3965353A (en) Cross-sectional X-ray emission imaging system
US6597940B2 (en) Methods of detecting occlusion of the coronary artery system and imaging the heart
Derenzo et al. Analytical study of a high-resolution positron ring detector system for transaxial reconstruction tomography
US6671541B2 (en) Cardiovascular imaging and functional analysis system
US6448560B1 (en) Method and apparatus for gamma ray detection
US4833327A (en) High-resolution radioisotopic imaging system
GB2082030A (en) Multi-view collimators for scintillation cameras
US4111191A (en) Apparatus and method for examining blood vessels of interest by tracking position with respect to time of particles introduced therein
US7409240B1 (en) System and method for imaging myocardial infarction
CA1118110A (en) Coincidence analysis circuit for positron annihilation imaging device
US3688113A (en) Tomographic radiation sensitive device
ISHII et al. Measurement of heart chamber volumes by analysis of dilution curves simultaneously recorded by scintillation camera
US4485307A (en) Medical gamma ray imaging
JP2535762B2 (en) Simultaneous Scattering Counting Method with Gamma Absorber in Positron Tomography Equipment and Positron Tomography Equipment
US4224303A (en) Signalling particles for introduction into blood flowing through a vessel of interest
Miller et al. Measurement of global and regional left ventricular function by cardiac PET
EP0829022B1 (en) An apparatus for scintigraphic analysis, particularly a mammograph, with sub-millimetric spatial resolution
GB2054372A (en) Examining blood vessels
Shaw Particles for introduction into the blood of a subject to interact with apparatus that can detect signals outside the body of the subject
CA1147067A (en) Particles for introduction into the blood of a subject to interact with apparatus that can detect signals outside the body of the subject
Shaw Examining blood vessels
CA1121522A (en) Apparatus and method for examining a blood vessel of interest using radiation detected outside the body
Shaw Apparatus and method for examining a blood vessel of interest using radiation detected outside the body
GB2072839A (en) Apparatus for Detecting, Localizing and Quantifying Coronary Stenoses from the Body Surface using Gamma-ray-emitting Particles and Coded Apertures

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee